MRT-2359
Monte Rosa Therapeutics
[]
monte rosa therapeutics presents preclinical data from gspt1 degrader program focused on myc-driven cancers at aacr 2023 
We provide a complete array of research services as required for Investigational New Drug Applications (IND).